Sarcopenia in end-stage kidney disease patients requiring dialysis is a frequent
complication but remains an under-recognized problem. This meta-analysis was conducted …

Sarcopenia is a risk factor for adverse clinical outcomes in chronic kidney disease (CKD)
patients, including mortality. Diagnosis depends on adopted consensus definition and cutoff …

Sarcopenia and sarcopenic obesity in chronic kidney disease:... : Current Opinion in Clinical
Nutrition & Metabolic Care Sarcopenia and sarcopenic obesity in chronic kidney disease …

Many countries are facing the advent of super-aging societies, where sarcopenia and frailty
will become pertinent problems. The prevalence of comorbidities is a major problem in …

Introduction Chronic kidney disease (CKD) causes a progressive loss of muscle and bone
mass, which frequently overlap with and affect clinical outcomes. However, the impact of …

Muscle fat infiltration (MFI) also known as myosteatosis refers to any deposit of lipids found
in the skeletal muscle. MFI is preferably assessed by image-based methods like computed …

The bioelectrical impedance analysis-measured ratio of extracellular water (ECW) to
intracellular water (ICW) reflects fluid volume and malnutrition. It may be an indicator of …

Background: Patients with chronic obstructive pulmonary disease (COPD) have alterations
in body composition, such as low cell integrity, body cell mass, and disturbances in water …

The aim of this narrative non-systematic review was to investigate the potential interplay
among frailty syndrome, sarcopenia and diabetic kidney disease (DKD) in type 2 diabetes …

Background The “pediatric inactivity triad” framework consists of three complex, interrelated
conditions influencing physical inactivity and associated health risks. Evidence on the …